prednisone has been researched along with montelukast in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (48.15) | 29.6817 |
2010's | 14 (51.85) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Geller, M | 1 |
Airaghi, L; Lorini, M; Suli, C; Tedeschi, A | 1 |
Murray, JA; Pardi, DS; Schwartz, DA | 1 |
Wergowske, GL | 1 |
Mastalerz, L; Nizankowska, E; Sanak, M; Szczeklik, A | 1 |
Neglia, JP; Tolar, J; Tope, WD | 1 |
Lei, S; Li, FY; Liu, CT; Mao, H; Wang, ZL; Yin, KS; Zhang, XL | 1 |
Deng, YL; Liu, CT; Mao, H; Wang, ZL; Yin, KS; Yu, YH | 1 |
Duong, M; Efthimiadis, A; Hargreave, FE; Jayaram, L; Kamada, D; Pizzichini, E; Pizzichini, MM | 1 |
Alawi, F; Ciarrocca, KN; DeRossi, SS | 1 |
Bacharier, LB; Boehmer, SJ; Covar, RA; Guilbert, TW; Jackson, DJ; Larsen, G; Lemanske, RF; Martinez, FD; Mauger, DT; Morgan, WJ; Moss, MH; Sorkness, CA; Spahn, JD; Strunk, RC; Szefler, SJ; Taussig, LM; Zeiger, RS | 1 |
Castells, MC; Liu, A; Ross, JJ; Saavedra, A; Vleugels, RA | 1 |
Rosenberg, JL | 1 |
Shaker, OG; Sourour, DA | 1 |
Caughey, GH; Dhaliwal, G; Pile, J; Prabhakaran, A; Schilf, CR | 1 |
Jawhari, N; Strauss, RA | 1 |
Fang, S; Li, C; Song, Y; Zhang, S | 1 |
2 review(s) available for prednisone and montelukast
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A shocking diagnosis.
Topics: Acetates; Aged; Anti-Inflammatory Agents; Cyclopropanes; Diagnosis, Differential; Humans; Hypotension; Leukotriene Antagonists; Male; Mastocytosis, Systemic; Prednisone; Quinolines; Sulfides; Tachycardia | 2017 |
2 trial(s) available for prednisone and montelukast
Article | Year |
---|---|
Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma.
Topics: Acetates; Adult; Aged; Analysis of Variance; Asthma; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Eosinophilia; Eosinophils; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Prednisone; Probability; Quinolines; Reference Values; Respiratory Function Tests; Risk Assessment; Severity of Illness Index; Sputum; Sulfides; Treatment Failure | 2005 |
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Eczema; Female; Fluticasone; Forced Expiratory Volume; Glucocorticoids; Humans; Leukotriene Antagonists; Logistic Models; Male; Prednisone; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2010 |
23 other study(ies) available for prednisone and montelukast
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Marked peripheral edema associated with montelukast and prednisone.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Drug Interactions; Edema; Humans; Male; Prednisone; Quinolines; Sulfides | 2000 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-2000. A 25-year-old man with asthma, cardiac failure, diarrhea, and weakness of the right hand.
Topics: Acetates; Adult; Androstadienes; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Diagnosis, Differential; Diarrhea; Fluticasone; Glucocorticoids; Heart Failure; Humans; Leukotriene Antagonists; Lung; Male; Muscle Hypotonia; Prednisone; Quinolines; Radiography; Sulfides | 2000 |
Successful treatment of chronic urticaria.
Topics: Acetates; Adult; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Leukotriene Antagonists; Prednisone; Quinolines; Sulfides; Urticaria | 2000 |
Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis.
Topics: Acetates; Adult; Cyclopropanes; Eosinophilia; Gastroenteritis; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Prednisone; Quinolines; Recurrence; Sulfides | 2001 |
Treatment-resistant atopic dermatitis.
Topics: Acetates; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antipruritics; Cyclopropanes; Dermatitis, Atopic; Diabetes Complications; Female; Humans; Hydroxyzine; Leukotriene Antagonists; Prednisone; Quinolines; Sulfides; Treatment Failure | 2001 |
Montelukast for persistent asthma.
Topics: Acetates; Anti-Asthmatic Agents; Aspirin; Asthma; Cyclopropanes; Humans; Leukotriene E4; Prednisone; Quinolines; Sulfides | 2001 |
Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.
Topics: Acetates; Anti-Inflammatory Agents; Cyclopropanes; Drug Therapy, Combination; Humans; Infant; Leukotriene Antagonists; Male; Mastocytosis, Systemic; Prednisone; Quinolines; Sulfides | 2004 |
Effects of glucocorticoid and cysteinyl leukotriene 1 receptor antagonist on CD(34+) hematopoietic cells in bone marrow of asthmatic mice.
Topics: Acetates; Animals; Antigens, CD34; Asthma; Cell Count; Cyclopropanes; Hematopoietic Stem Cells; Immunohistochemistry; In Situ Hybridization; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Prednisone; Quinolines; Sulfides | 2004 |
[The effects of anti-inflammatory and anti-asthmatic agents on CD34+ hematopoietic cells in bone marrow of asthmatic mice].
Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antigens, CD34; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Hematopoietic Stem Cells; Interleukin-5 Receptor alpha Subunit; Male; Mice; Mice, Inbred BALB C; Prednisone; Quinolines; Receptors, Interleukin; RNA, Messenger; Sulfides | 2004 |
Oral ulcerations in a patient with severe asthma.
Topics: Acetates; Adrenal Cortex Hormones; Aged; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Diagnosis, Differential; Female; Histoplasmosis; Humans; Immunosuppression Therapy; Leukotriene Antagonists; Mouth Mucosa; Mouth Neoplasms; Oral Ulcer; Prednisone; Quinolines; Severity of Illness Index; Stomatitis, Aphthous; Sulfides; Tongue Diseases | 2010 |
Interactive medical case. A rash hypothesis.
Topics: Acetates; Adult; Anti-Inflammatory Agents; Cromolyn Sodium; Cyclopropanes; Diarrhea; Drug Therapy, Combination; Enzyme Inhibitors; Exanthema; Female; Flushing; Histamine H2 Antagonists; Humans; Leukotriene Antagonists; Mastocytosis, Systemic; Prednisone; Protein-Tyrosine Kinases; Quinolines; Ranitidine; Staurosporine; Sulfides; Tryptases; Vomiting | 2010 |
Lack of pretreatment cost-effectiveness and side effects of omalizumab versus prednisone/montelukast on tolerability of immunotherapy.
Topics: Acetates; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Asthma; Cost-Benefit Analysis; Cyclopropanes; Desensitization, Immunologic; Humans; Hypersensitivity; Omalizumab; Prednisone; Quinolines; Sulfides | 2011 |
Effect of leukotriene receptor antagonists on lung fibrosis in rats.
Topics: Acetates; Animals; Bleomycin; Collagen; Cyclopropanes; Dose-Response Relationship, Drug; Drug Combinations; Hydroxyproline; Leukotriene Antagonists; Lung; Male; Prednisone; Pulmonary Fibrosis; Quinolines; Rats; Sulfides | 2011 |
Mepolizumab in the treatment of severe eosinophilic asthma: Results from a physician in the field.
Topics: Acetates; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Antibodies, Monoclonal, Humanized; Asthma; Cyclopropanes; Drug Administration Schedule; Eosinophils; Female; Humans; Injections, Subcutaneous; Interleukin-5; Male; Middle Aged; Prednisone; Pulmonary Eosinophilia; Quinolines; Retrospective Studies; Rhinitis, Allergic; Severity of Illness Index; Sulfides; Surveys and Questionnaires | 2018 |
Retrospective study of budesonide in children with eosinophilic gastroenteritis.
Topics: Acetates; Adolescent; Biopsy; Budesonide; Child; Child, Preschool; Cyclopropanes; Endoscopy; Enteritis; Eosinophilia; Eosinophils; Female; Gastritis; Humans; Infant; Male; Prednisone; Quinolines; Retrospective Studies; Sulfides; Treatment Outcome | 2019 |